| Literature DB >> 32867742 |
Zhu Wang1, Ming-Xing Li2, Chang-Zhi Xu3, Ying Zhang4, Qiong Deng4, Rui Sun4, Qi-Yi Hu4, Sheng-Ping Zhang4, Jian-Wen Zhang4, Hui Liang5.
Abstract
BACKGROUND: Calcium oxalate monohydrate (COM), the major crystalline composition of most kidney stones, induces inflammatory infiltration and injures in renal tubular cells. However, the mechanism of COM-induced toxic effects in renal tubular cells remain ambiguous. The present study aimed to investigate the potential changes in proteomic landscape of proximal renal tubular cells in response to the stimulation of COM crystals.Entities:
Keywords: Calcium oxalate crystal; Kidney stone; Protein expression profile; Renal epithelial cells
Mesh:
Substances:
Year: 2020 PMID: 32867742 PMCID: PMC7461262 DOI: 10.1186/s12894-020-00709-z
Source DB: PubMed Journal: BMC Urol ISSN: 1471-2490 Impact factor: 2.264
Fig. 1COM-HK-2 cell preparation and protein sample quality control. a. Representative pictures of calcium oxalate monohydrate crystals treated HK-2 cells and its’ parental control. COM crystal adhesion and cell-crystal interactions. Images were taken using phase-contrast microscopy. b. Protein information of quality control. c. Protein coverage distribution of quality control
Fig. 2Proteome alterations of HK-2 cells after treated with calcium oxalate crystals. a. Scatter plot of differential expressed proteins statistics. b. Histogram of differential expressed proteins
Upregulated proteins in COM-stimulated HK-2 cells (P < 0.05, FC > 2)
| Gene name | Accession | FC (C/H) | Description | |
|---|---|---|---|---|
| LZTS1 | Q9Y250 | 20.20 | 0.001 | Leucine zipper putative tumor suppressor 1 OS=Homo sapiens GN = LZTS1 PE = 1 SV = 3 |
| HES1 | Q14469 | 16.53 | 0.001 | Transcription factor HES-1 OS=Homo sapiens GN=HES1 PE = 1 SV = 1 |
| NKTR | P30414 | 9.53 | 0.001 | NK-tumor recognition protein OS=Homo sapiens GN=NKTR PE = 1 SV = 2 |
| KLK15 | M0R2F7 | 3.51 | 0.033 | Kallikrein-15 (Fragment) OS=Homo sapiens GN=KLK15 PE = 4 SV = 1 |
| CLPS | P04118 | 3.30 | 0.002 | Colipase OS=Homo sapiens GN=CLPS PE = 1 SV = 2 |
| DPP8 | Q6V1X1 | 3.09 | 0.004 | Dipeptidyl peptidase 8 OS=Homo sapiens GN = DPP8 PE = 1 SV = 1 |
| CEP128 | Q6ZU80 | 2.77 | 0.004 | Centrosomal protein of 128 kDa OS=Homo sapiens GN=CEP128 PE = 1 SV = 2 |
| PHRF1 | Q9P1Y6 | 2.74 | 0.003 | PHD and RING finger domain-containing protein 1 OS=Homo sapiens GN=PHRF1 PE = 1 SV = 3 |
| HNRNPD | D6RBQ9 | 2.64 | 0.007 | Heterogeneous nuclear ribonucleoprotein D0 (Fragment) OS=Homo sapiens GN=HNRNPD PE = 1 SV = 1 |
| ANXA2 | H0YL33 | 2.63 | 0.015 | Annexin (Fragment) OS=Homo sapiens GN = ANXA2 PE = 1 SV = 1 |
| TMEM141 | Q96I45 | 2.61 | 0.000 | Transmembrane protein 141 OS=Homo sapiens GN = TMEM141 PE = 1 SV = 1 |
| FAU | E9PM49 | 2.53 | 0.001 | 40S ribosomal protein S30 (Fragment) OS=Homo sapiens GN=FAU PE = 1 SV = 8 |
| TMSB10 | P63313 | 2.49 | 0.009 | Thymosin beta-10 OS=Homo sapiens GN = TMSB10 PE = 1 SV = 2 |
| CFL1 | E9PP50 | 2.38 | 0.013 | Cofilin-1 (Fragment) OS=Homo sapiens GN=CFL1 PE = 1 SV = 8 |
| RPS29 | P62273 | 2.35 | 0.024 | 40S ribosomal protein S29 OS=Homo sapiens GN = RPS29 PE = 1 SV = 2 |
| ACTB | C9JTX5 | 2.34 | 0.000 | Actin, cytoplasmic 1 (Fragment) OS=Homo sapiens GN = ACTB PE = 1 SV = 1 |
| ZNF12 | P17014 | 2.32 | 0.001 | Zinc finger protein 12 OS=Homo sapiens GN = ZNF12 PE = 1 SV = 3 |
| GCHFR | P30047 | 2.27 | 0.013 | GTP cyclohydrolase 1 feedback regulatory protein OS=Homo sapiens GN = GCHFR PE = 1 SV = 3 |
| ZNF146 | Q15072 | 2.23 | 0.000 | Zinc finger protein OZF OS=Homo sapiens GN = ZNF146 PE = 1 SV = 2 |
| TMEM222 | Q9H0R3 | 2.17 | 0.002 | Transmembrane protein 222 OS=Homo sapiens GN = TMEM222 PE = 1 SV = 2 |
| ZNF574 | A0A0C4DFM2 | 2.16 | 0.000 | HCG1643764, isoform CRA_b OS=Homo sapiens GN = ZNF574 PE = 1 SV = 1 |
| TSHZ1 | Q6ZSZ6 | 2.11 | 0.006 | Teashirt homolog 1 OS=Homo sapiens GN = TSHZ1 PE = 1 SV = 2 |
| ITGA5 | P08648 | 2.04 | 0.007 | Integrin alpha-5 OS=Homo sapiens GN=ITGA5 PE = 1 SV = 2 |
| BTF3 | D6RDG3 | 2.02 | 0.004 | Transcription factor BTF3 (Fragment) OS=Homo sapiens GN=BTF3 PE = 1 SV = 3 |
Down-regulated proteins in COM-stimulated HK-2 cells (P < 0.05, FC < 0.6)
| Gene name | Accession | FC (C/H) | Description | |
|---|---|---|---|---|
| PRDX1 | Q06830 | 0.57 | 0.001 | Peroxiredoxin-1 OS=Homo sapiens GN=PRDX1 PE = 1 SV = 1 |
| NME2P1 | O60361 | 0.57 | 0.029 | Putative nucleoside diphosphate kinase OS=Homo sapiens GN=NME2P1 PE = 5 SV = 1 |
| SLC39A10 | Q9ULF5 | 0.57 | 0.001 | Zinc transporter ZIP10 OS=Homo sapiens GN=SLC39A10 PE = 1 SV = 2 |
| SERPINB1 | P30740 | 0.56 | 0.006 | Leukocyte elastase inhibitor OS=Homo sapiens GN=SERPINB1 PE = 1 SV = 1 |
| FAM133B | Q5BKY9 | 0.56 | 0.014 | Protein FAM133B OS=Homo sapiens GN=FAM133B PE = 1 SV = 1 |
| PRDX2 | P32119 | 0.56 | 0.003 | Peroxiredoxin-2 OS=Homo sapiens GN=PRDX2 PE = 1 SV = 5 |
| MYL12A | J3QRS3 | 0.56 | 0.012 | Myosin regulatory light chain 12A OS=Homo sapiens GN = MYL12A PE = 1 SV = 1 |
| MYH14 | Q7Z406 | 0.55 | 0.002 | Myosin-14 OS=Homo sapiens GN = MYH14 PE = 1 SV = 2 |
| MAP10 | Q9P2G4 | 0.55 | 0.017 | Microtubule-associated protein 10 OS=Homo sapiens GN = MAP10 PE = 1 SV = 2 |
| PADI2 | Q9Y2J8 | 0.54 | 0.012 | Protein-arginine deiminase type-2 OS=Homo sapiens GN=PADI2 PE = 1 SV = 2 |
| C14orf1 | Q9UKR5 | 0.54 | 0.003 | Probable ergosterol biosynthetic protein 28 OS=Homo sapiens GN=C14orf1 PE = 1 SV = 1 |
| MYH9 | P35579 | 0.53 | 0.010 | Myosin-9 OS=Homo sapiens GN = MYH9 PE = 1 SV = 4 |
| MT-ND2 | P03891 | 0.50 | 0.010 | NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN = MT-ND2 PE = 1 SV = 2 |
| APITD1-CORT | A0A087WT10 | 0.47 | 0.001 | APITD1-CORT readthrough OS=Homo sapiens GN = APITD1-CORT PE = 1 SV = 1 |
| TUFT1 | Q9NNX1 | 0.47 | 0.015 | Tuftelin OS=Homo sapiens GN = TUFT1 PE = 1 SV = 1 |
| SERPINB6 | A0A087X1N8 | 0.26 | 0.000 | Serpin B6 OS=Homo sapiens GN=SERPINB6 PE = 1 SV = 1 |
Fig. 3Heatmap and cluster analysis of differential expressed proteins. Proteins fold change (FC) > 2 or < 0.6 and p < 0.05 were enriched
Fig. 4GO analysis. Each column is a GO term, the abscissa indicates the GO name and the classification, the height of the column indicates the enrichment rate, and the p value is represented by the color. The darker the color, the more significant. ***, p < 0.001; **, p < 0.01; *, p < 0.05
Fig. 5GO level-2 distribution of differential expression proteins. a. Biological process. b. Cellular process. c. Molecular function. Results showed that most of the differential expressed proteins are related to cellular process, cell part and binding
GO terms of the differentially expressed proteins involved in COM-stimulated HK-2 cells
| Name | Namespace | Count | |
|---|---|---|---|
| Cell part | Cellular component | 30 | 0.002 |
| Organelle | Cellular component | 24 | 0.003 |
| Membrane | Cellular component | 13 | 0.038 |
| Organelle part | Cellular component | 17 | 0.001 |
| Macromolecular complex | Cellular component | 10 | 0.021 |
| Extracellular region | Cellular component | 5 | 0.046 |
| Synapse | Cellular component | 3 | 0.044 |
| Cellular process | Biological process | 26 | 0.009 |
| Response to stimulus | Biological process | 6 | 0.046 |
| Detoxification | Biological process | 2 | 0.020 |
| Antioxidant activity | Molecular function | 2 | 0.017 |
| Binding | Molecular function | 28 | 0.019 |
| Catalytic activity | Molecular function | 10 | 0.018 |
Fig. 6KEEG analysis. Each column is a pathway, the abscissa indicates the name and the classification, the height of the column indicates the enrichment rate, and the p value is represented by the color. The darker the color, the more significant. Results showed that 11 pathways were significant changed in the COM treated HK-2 cells as compared to its untreated control. ***, p < 0.001; **, p < 0.01; *, p < 0.05
KEGG pathway analysis of the differentially expressed proteins involved in COM-stimulated HK-2 cells
| Pathway | Class | Count | |
|---|---|---|---|
| Regulation of actin cytoskeleton | Cellular Processes | 6 | 0.0001 |
| Tight junction | Cellular Processes | 4 | 0.004 |
| Focal adhesion | Cellular Processes | 3 | 0.0294 |
| Salmonella infection | Human Diseases | 3 | 0.0076 |
| Dilated cardiomyopathy (DCM) | Human Diseases | 2 | 0.0195 |
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | Human Diseases | 2 | 0.0211 |
| Hypertrophic cardiomyopathy (HCM) | Human Diseases | 2 | 0.0211 |
| Pertussis | Human Diseases | 2 | 0.0264 |
| Amoebiasis | Human Diseases | 2 | 0.041 |
| Shigellosis | Human Diseases | 2 | 0.0453 |
| Fanconi anemia pathway | Genetic Information Processing | 2 | 0.0301 |
Fig. 7Protein interaction networks of differential expressed proteins. According to the STRING database, the protein interaction networks of the DEPs contained 8 main nodes and 21 connections. Each node in the network represents a protein molecule, and the line represents the interaction between proteins. The wider the line, the higher the score, and the narrower the line, the lower the score. The top 3 high-score hub nodes included CFL1, ACTN and MYH9. The interaction between CFL1 and ACTN exhibited the highest combined score of 0.999, suggested that may play vital roles in the adhesion of COM to the HK-2 cells